| Pharmaceutical Information |
| Drug Name |
Cinoxacin |
| Drug ID |
BADD_D00470 |
| Description |
Synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections. |
| Indications and Usage |
For the treatment of initial and recurrent urinary tract infections in adults caused by the following susceptible microorganisms: Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella species (including K. pneumoniae), and Enterobacter species. |
| Marketing Status |
approved; investigational; withdrawn |
| ATC Code |
J01MB06 |
| DrugBank ID |
DB00827
|
| KEGG ID |
D00872
|
| MeSH ID |
D002937
|
| PubChem ID |
2762
|
| TTD Drug ID |
D07UXP
|
| NDC Product Code |
Not Available |
| UNII |
LMK22VUH23
|
| Synonyms |
Cinoxacin | Clinoxacin | Azolinic Acid | Acid, Azolinic | Compound 64716 | Cinobac |
|
| Chemical Information |
| Molecular Formula |
C12H10N2O5 |
| CAS Registry Number |
28657-80-9 |
| SMILES |
CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
